What is the price target for MDWD stock?
12 analysts have analysed MDWD and the average price target is 30.4 USD. This implies a price increase of 73.2% is expected in the next year compared to the current price of 17.55.
NASDAQ:MDWD • IL0011316309
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDIWOUND LTD (MDWD).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-11-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-28 | Craig-Hallum | Initiate | Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-17 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-31 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-04 | HC Wainwright & Co. | Maintains | Buy |
| 2022-12-30 | Cowen & Co. | Maintains | Outperform |
| 2022-12-22 | Maxim Group | Initiate | Buy |
| 2022-12-21 | Oppenheimer | Maintains | Outperform |
| 2022-11-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-18 | Wells Fargo | Maintains | Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.686M -29.49% | 20.222M 8.22% | 16.959M -16.14% | 25.248M 48.88% | 34.105M 35.08% | 54.658M 60.26% | 109.19M 99.77% | 180.92M 65.69% | 211.87M 17.11% | 271.85M 28.31% | 379.49M 39.60% | |
| EBITDA YoY % growth | -14.198M -129.37% | -17.917M -26.19% | -23.406M -30.64% | -34.34M -46.72% | -29.5M 14.09% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.501M -107.79% | -19.4M -25.15% | -25.266M -30.24% | -34.895M -38.11% | -28.24M 19.07% | -19.034M 32.60% | 11.683M 161.38% | 51.75M 342.95% | 72.033M 39.19% | 116.45M 61.66% | 187.06M 60.64% | |
| Operating Margin | -82.96% | -95.94% | -148.98% | -138.21% | -82.80% | -34.82% | 10.70% | 28.60% | 34.00% | 42.84% | 49.29% | |
| EPS YoY % growth | -0.77 79.58% | -3.07 -298.70% | -2.10 31.60% | -2.81 -33.65% | -2.08 25.80% | -1.27 39.10% | 0.65 151.47% | 2.41 269.53% | 4.56 89.01% | 6.78 48.77% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.67 -852.00% | -0.72 41.68% | -0.72 -201.04% | -0.69 -22.95% | -0.52 21.94% | -0.53 25.59% | -0.53 26.12% | -0.51 25.93% |
| Revenue Q2Q % growth | 3.176M -19.70% | 4.925M -13.72% | 7.801M 43.69% | 9.821M 426.03% | 7.85M 147.17% | 8.169M 65.87% | 8.772M 12.45% | 9.273M -5.58% |
| EBITDA Q2Q % growth | -7.962M -63.59% | -8.701M -75.27% | -9.035M -68.72% | -8.693M -46.35% | -7.3M 8.31% | -7.548M 13.25% | -7.625M 15.61% | -7.008M 19.39% |
| EBIT Q2Q % growth | -8.362M -60.05% | -9.037M -58.10% | -9.411M -44.23% | -9.294M -19.15% | -7.327M 12.38% | -7.616M 15.73% | -7.65M 18.71% | -7.356M 20.85% |
All data in USD
12 analysts have analysed MDWD and the average price target is 30.4 USD. This implies a price increase of 73.2% is expected in the next year compared to the current price of 17.55.
MEDIWOUND LTD (MDWD) will report earnings on 2026-05-19.
The consensus EPS estimate for the next earnings of MEDIWOUND LTD (MDWD) is -0.67 USD and the consensus revenue estimate is 3.18M USD.
The consensus rating for MEDIWOUND LTD (MDWD) is 83.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.